mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.06 |
mRNA |
simvastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.06 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.06 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.07 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.07 |
mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.07 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.07 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.08 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.09 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.09 |